We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+11.08%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$134B
AUM Growth
+$14.8B
Cap. Flow
+$2.42B
Cap. Flow %
1.81%
Top 10 Hldgs %
25.29%
Holding
4,017
New
232
Increased
1,652
Reduced
1,816
Closed
191

Sector Composition

Rank Sector Weight
1 Technology 15.71%
2 Financials 9.02%
3 Healthcare 7.82%
4 Industrials 6.8%
5 Consumer Discretionary 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCN
3526
Madison Covered Call & Equity Strategy Fund
MCN
$119M
$195K ﹤0.01%
25,923
+269
+1% +$1.9K
FUSN
3527
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$194K ﹤0.01%
+20,200
New +$98.2K
HPF
3528
John Hancock Preferred Income Fund II
HPF
$345M
$193K ﹤0.01%
12,239
-4,742
-28% -$69.1K
GDRX icon
3529
GoodRx Holdings
GDRX
$1.27B
$192K ﹤0.01%
+28,600
New +$161K
SHYF
3530
DELISTED
The Shyft Group
SHYF
$192K ﹤0.01%
15,672
-1,152
-7% -$14.1K
MMT
3531
Aberdeen Multi-Market Income Fund
MMT
$244M
$191K ﹤0.01%
42,054
-2,306
-5% -$10K
BSL
3532
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$170M
$190K ﹤0.01%
14,225
+227
+2% +$2.96K
WNEB icon
3533
Western New England Bancorp
WNEB
$282M
$189K ﹤0.01%
21,012
-1,268
-6% -$9.67K
QIPT
3534
DELISTED
Quipt Home Medical
QIPT
$188K ﹤0.01%
37,000
+10,000
+37% +$47.9K
BHR
3535
Braemar Hotels & Resorts
BHR
$139M
$185K ﹤0.01%
73,900
+10,000
+16% +$24.9K
ADTH
3536
DELISTED
AdTheorent Holding Co
ADTH
$184K ﹤0.01%
127,000
AGL icon
3537
Agilon Health
AGL
$1.49B
$184K ﹤0.01%
+587
New +$212K
CGEN icon
3538
Compugen
CGEN
$228M
$183K ﹤0.01%
92,625
-10,000
-10% -$8.74K
GOOD
3539
Gladstone Commercial Corp
GOOD
$641M
$182K ﹤0.01%
13,777
-520
-4% -$6.51K
GLU
3540
Gabelli Utility & Income Trust
GLU
$116M
$182K ﹤0.01%
13,834
-3,693
-21% -$47K
JRVR icon
3541
James River Group Holdings
JRVR
$200M
$181K ﹤0.01%
19,631
-22
-0.1% -$253
PDT
3542
John Hancock Premium Dividend Fund
PDT
$628M
$181K ﹤0.01%
17,007
-2,769
-14% -$27.9K
FUBO icon
3543
FuboTV Inc
FUBO
$296M
$180K ﹤0.01%
4,724
+3,266
+224% +$113K
TME icon
3544
Tencent Music
TME
$14.2B
$179K ﹤0.01%
19,891
-5,490
-22% -$42.5K
QS icon
3545
QuantumScape Corp
QS
$3.79B
$179K ﹤0.01%
25,786
+3,158
+14% +$19.9K
TGB
3546
Trekor Metals
TGB
$3.08B
$177K ﹤0.01%
126,443
-45,000
-26% -$55.3K
TWO
3547
Two Harbors Investment
TWO
$1.26B
$177K ﹤0.01%
12,698
+160
+1% +$2.07K
XPEV icon
3548
XPeng
XPEV
$11.3B
$173K ﹤0.01%
11,878
-1,312
-10% -$20.9K
SEAT icon
3549
Vivid Seats
SEAT
$80.5M
$172K ﹤0.01%
+1,360
New +$186K
HEQ
3550
John Hancock Hedged Equity & Income Fund
HEQ
$141M
$171K ﹤0.01%
16,999
+1,594
+10% +$15.4K

Similar funds

Raymond James & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Raymond James & Associates held 4,017 positions worth $134B, up 12% from $119B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q4 2023 filing shows 232 new, 1,652 increased, 1,816 reduced and 191 closed positions. Its largest new stake was Delek US: 515,324 shares worth $13.3M. The largest sale was Pioneer Natural Resource Co., an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2023 buy was Delek US: 515,324 shares worth $13.3M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $219M increase.
  • Raymond James & Associates's biggest Q4 2023 reduction was Pioneer Natural Resource Co., cutting an estimated $124M.
  • Raymond James & Associates fully exited Kayne Anderson NextGen Energy & Infrastructure, Inc. in Q4 2023, selling an estimated $22.8M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $134B portfolio in Q4 2023.
  • Raymond James & Associates opened 232 new positions and closed 191 in Q4 2023.
  • Raymond James & Associates's portfolio value rose 12% quarter-over-quarter to $134B.

Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.